Search for: "E Merck"
Results 61 - 80
of 391
Sorted by Relevance
|
Sort by Date
9 Jan 2008, 2:41 pm
AEI resident scholar John E. [read post]
29 Jul 2011, 7:59 pm
District Judge Garrett E. [read post]
16 Apr 2019, 2:33 am
What is E. coli? [read post]
1 Dec 2009, 12:00 pm
Section 9(e) was triggered only by discovery. [read post]
4 Aug 2011, 8:30 am
Merck & Co., 2011 U.S. [read post]
12 Mar 2012, 6:04 am
Merck & Co. [read post]
31 Aug 2011, 9:52 am
The judgment of non-infringement is affirmed as to Merck, and is vacated as to Biogen and GlaxoSmithKline insofar as based on §271(e)(1). [read post]
31 Aug 2011, 9:56 pm
Medtronic and Merck v. [read post]
20 Mar 2008, 8:18 am
Implementing in other contexts this broadly stated congressional policy, in Merck KgaA v. [read post]
27 Oct 2023, 6:02 am
Sources, Characteristics, and Identification E. coli is an archetypal commensal bacterial species that lives in mammalian intestines. [read post]
23 Apr 2007, 3:32 pm
District Court Judge Eldon E. [read post]
9 Feb 2012, 9:09 am
http://www.freepatentsonline.com/8110510.htmlThis patent from Merck Patent GmbH teaches techniques to lower the fabrication temperature of semiconductor nanowires to below 400 C. [read post]
11 Jan 2008, 6:11 am
District Judge Eldon E. [read post]
10 Oct 2008, 1:15 am
The settlement tops the $58 million paid by Merck over Vioxx marketing as the largest paid by a drug company in a state consumer protection case. [read post]
13 Aug 2012, 9:41 pm
By Kevin E. [read post]
22 Oct 2017, 9:59 pm
By Kevin E. [read post]
4 Oct 2022, 11:47 am
In a nutshell, the reason for this was that under pre-AIA 35 U.S.C. 103(c)(1) Edmondson could not be used as 102(e)/103 prior art because Edmondson and the challenged patent were both owned by Merck, and Merck was able to antedate Edmondson as a 102(a)/103 reference with respect to Claim 1 and some of the other claims at issue. [read post]
30 Mar 2007, 10:26 am
In Merck & Co. v. [read post]
17 Nov 2007, 11:01 pm
Merck's claimed privilege over approximately 500,000 pages of documents, primarily e-mails and attachments between Merck in-house attorneys and non-legal personnel. [read post]
27 Mar 2024, 4:46 pm
” Merck KGaA v. [read post]
